Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Holdings
NU
|
+$90.5M |
| 2 |
SW
Smurfit Westrock
SW
|
+$70M |
| 3 |
Pinduoduo
PDD
|
+$28.2M |
| 4 |
Microsoft
MSFT
|
+$24.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$118M |
| 2 |
Apple
AAPL
|
+$43.5M |
| 3 |
WRK
WestRock Company
WRK
|
+$38.2M |
| 4 |
Danaher
DHR
|
+$27.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.62% |
| 2 | Healthcare | 12.18% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 9.21% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
CleanSpark
CLSK
$2.96B
| $4.24M | ﹤0.01% |
453,900
+10,600
| +2% | +$135K |
|
1427
Strategic Education
STRA
$1.81B
| $4.23M | ﹤0.01% |
45,738
+2,100
| +5% | +$212K |
|
1428
Energizer
ENR
$1.56B
| $4.23M | ﹤0.01% |
133,225
-1,300
| -1% | -$39.1K |
|
1429
Arrowhead Research
ARWR
$12.3B
| $4.23M | ﹤0.01% |
218,300
-25,000
| -10% | -$610K |
|
1430
ADT
ADT
$5.34B
| $4.23M | ﹤0.01% |
584,521
-4,400
| -0.7% | -$32.3K |
|
1431
InvenTrust Properties
IVT
$2.59B
| $4.22M | ﹤0.01% |
148,800
+15,700
| +12% | +$436K |
|
|
NARI
1432
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $4.22M | ﹤0.01% |
102,300
| – | – |
|
1433
Bloom Energy
BE
$69.6B
| $4.22M | ﹤0.01% |
399,500
| – | – |
|
1434
IDEAYA Biosciences
IDYA
$3.56B
| $4.22M | ﹤0.01% |
133,100
+8,400
| +7% | +$319K |
|
|
IBTX
1435
DELISTED
Independent Bank Group, Inc.
IBTX
| $4.19M | ﹤0.01% |
72,722
-500
| -0.7% | -$27.3K |
|
1436
10x Genomics
TXG
$7.52B
| $4.19M | ﹤0.01% |
185,700
-1,400
| -0.7% | -$28.9K |
|
|
NVEI
1437
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $4.19M | ﹤0.01% |
125,400
| – | – |
|
1438
Goosehead Insurance
GSHD
$2.33B
| $4.19M | ﹤0.01% |
46,900
-300
| -0.6% | -$23.7K |
|
1439
Clarivate
CLVT
$1.25B
| $4.19M | ﹤0.01% |
589,800
| – | – |
|
1440
Riot Platforms
RIOT
$7.21B
| $4.18M | ﹤0.01% |
563,700
+90,000
| +19% | +$779K |
|
|
EQC
1441
DELISTED
Equity Commonwealth
EQC
| $4.17M | ﹤0.01% |
209,500
-1,100
| -0.5% | -$21.9K |
|
1442
Gibraltar Industries
ROCK
$1.46B
| $4.16M | ﹤0.01% |
59,500
-500
| -0.8% | -$34.9K |
|
1443
Vishay Intertechnology
VSH
$5.11B
| $4.16M | ﹤0.01% |
220,000
-2,100
| -0.9% | -$43.7K |
|
1444
Vertex
VERX
$2.15B
| $4.15M | ﹤0.01% |
107,800
-2,700
| -2% | -$99.5K |
|
1445
Powell Industries
POWL
$7.43B
| $4.15M | ﹤0.01% |
56,100
-600
| -1% | -$32.7K |
|
1446
Mirion Technologies
MIR
$3.79B
| $4.15M | ﹤0.01% |
374,800
+31,200
| +9% | +$328K |
|
1447
FIVE9
FIVN
$2.53B
| $4.15M | ﹤0.01% |
144,300
-1,000
| -0.7% | -$36.1K |
|
|
CPRX
1448
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.13M | ﹤0.01% |
207,600
-1,200
| -0.6% | -$22.2K |
|
|
VGR
1449
DELISTED
Vector Group Ltd.
VGR
| $4.12M | ﹤0.01% |
276,473
-2,700
| -1% | -$36.4K |
|
1450
OFG Bancorp
OFG
$2.26B
| $4.12M | ﹤0.01% |
91,800
-1,000
| -1% | -$43K |
|
Similar funds
Swiss National Bank's Q3 2024 Portfolio in Review
As of Q3 2024, Swiss National Bank held 2,510 positions worth $154B, up 5.8% from $146B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 3.9%. Swiss National Bank opened 52 new positions and exited 45, leaving the 2,510-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2024 buy was Nu Holdings: 6,729,657 shares worth $91.9M.
- Swiss National Bank added most to Pinduoduo in Q3 2024, an estimated $28.2M increase.
- Swiss National Bank's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $118M.
- Swiss National Bank fully exited WestRock Company in Q3 2024, selling an estimated $38.2M.
- Swiss National Bank's ten largest holdings make up 32% of its $154B portfolio in Q3 2024.
- Swiss National Bank opened 52 new positions and closed 45 in Q3 2024.
- Swiss National Bank's portfolio value rose 5.8% quarter-over-quarter to $154B.
Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.